{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:59:45Z","timestamp":1791388785286,"version":"4.3.3"},"reference-count":54,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Acquired reactive perforating collagenosis (ARPC) is a rare entity usually occurring in adults with systemic diseases such as diabetes mellitus, chronic kidney disease (CKD), cardiovascular diseases, and malignancies, although drug-related and trauma-induced cases have also been reported. Given its rarity and the lack of consensus on optimal management, we conducted a systematic review to summarize updated diagnostic and therapeutic insights into ARPC. Additionally, we report a case of ARPC associated with CKD. Methods: This study was conducted in accordance with the PRISMA 2020 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A literature search was performed in the PubMed database between May\u2013September 2025. The search strategy targeted open-access, primary human studies, published within the last 15 years, available in English, and including adult patients with histopathologically confirmed ARPC. Results: Twenty-seven studies, predominantly case reports and case series, were included. The mean patient age was 60.8 \u00b1 14.4 years. Only one case occurred in the absence of comorbidities, while most subjects had underlying systemic diseases. Drug-induced cases were also described. Clinically, ARPC should be suspected in patients presenting with pruritic papules\/nodules with central keratotic plugs. Additional diagnostic tools include dermoscopy and reflectance confocal microscopy. However, histopathological evidence of transepidermal elimination of altered collagen fibers is mandatory. The current treatments of ARPC include antihistamines, keratolytics, topical\/intralesional\/oral corticosteroids, topical\/systemic retinoids, phototherapy, dupilumab and allopurinol. Other therapies have been reported across the literature, including emerging ones. Conclusions: Once ARPC is diagnosed, a thorough evaluation for underlying diseases, including malignancies, is essential. Clinical trials are warranted to define optimal therapeutic strategies.<\/jats:p>","DOI":"10.3390\/jcm15010391","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T12:38:56Z","timestamp":1767616736000},"page":"391","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acquired Reactive Perforating Collagenosis\u2014A Rare Entity Occurring Within Common Disorders: A Systematic Review and Our Personal Experience"],"prefix":"10.3390","volume":"15","author":[{"given":"Maria Alexandra","family":"Junghetu","sequence":"first","affiliation":[{"name":"Department of Oncologic Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, Elias University Emergency Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2840-1263","authenticated-orcid":false,"given":"Cristina Violeta","family":"Tutunaru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Laura","family":"Iano\u0219i","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Valentina","family":"Georgescu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-5736","authenticated-orcid":false,"given":"Olgu\u021ba Anca","family":"Orzan","sequence":"additional","affiliation":[{"name":"Department of Oncologic Dermatology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Dermatology, Elias University Emergency Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1346-8138.2010.00918.x","article-title":"Acquired reactive perforating collagenosis: Current status","volume":"37","author":"Karpouzis","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_2","unstructured":"Mullins, T.B., Sickinger, M., and Zito, P.M. (2025, October 05). Reactive Perforating Collagenosis, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459214\/."},{"key":"ref_3","first-page":"1707","article-title":"Perforating Diseases","volume":"Volume 2","author":"Bolognia","year":"2024","journal-title":"Dermatology"},{"key":"ref_4","first-page":"723","article-title":"Acquired reactive perforating dermatosis","volume":"11","author":"Wagner","year":"2013","journal-title":"JDDG J. Der Dtsch. Dermatol. Ges."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1503\/cmaj.082013","article-title":"Acquired perforating dermatosis: Association with diabetes and renal failure","volume":"181","author":"Lynde","year":"2009","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2133.1999.02722.x","article-title":"Acquired reactive perforating collagenosis associated with diabetes mellitus: Eight cases that meet Faver\u2019s criteria","volume":"140","author":"Kawakami","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM198201143060206","article-title":"Reactive perforating collagenosis associated with diabetes mellitus","volume":"306","author":"Poliak","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3346\/jkms.2004.19.2.283","article-title":"Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus","volume":"19","author":"Hong","year":"2004","journal-title":"J. Korean Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5812\/nephropathol.9873","article-title":"Dermatological diseases in patients with chronic kidney disease","volume":"2","author":"Gagnon","year":"2013","journal-title":"J. Nephropathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1093\/ndt\/12.12.2774","article-title":"Acquired perforating dermatosis in renal patients","volume":"12","author":"Maurice","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(94)70065-6","article-title":"Acquired reactive perforating collagenosis: Report of six cases and review of the literature","volume":"30","author":"Faver","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1468-3083.2006.01571.x","article-title":"Acquired perforating dermatosis: Clinicopathological features in twenty-two cases","volume":"20","author":"Saray","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1346-8138.2007.00346.x","article-title":"Characteristics of acquired reactive perforating collagenosis","volume":"34","author":"Tsuboi","year":"2007","journal-title":"J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/CM9.0000000000000906","article-title":"Acquired reactive perforating collagenosis","volume":"133","author":"Wang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.1503\/cmaj.091185","article-title":"Acquired reactive perforating collagenosis","volume":"182","author":"Kreuter","year":"2010","journal-title":"Can. Med. Assoc. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2133.2001.04309.x","article-title":"Acquired perforating collagenosis: Is it due to damage by scratching?","volume":"145","author":"Schneider","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archderm.1970.04000090075012","article-title":"Reactive perforating collagenosis. Experimental production of the lesion","volume":"102","author":"Bovenmyer","year":"1970","journal-title":"Arch. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0378-6323.77468","article-title":"Reactive perforating collagenosis with a giant lesion at the site of healed herpes zoster","volume":"77","author":"Ghorpade","year":"2011","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaad.2008.06.006","article-title":"Up-regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis","volume":"60","author":"Gambichler","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2004.02.025","article-title":"Acquired perforating dermatosis: A report on 4 cases associated with scabies infection","volume":"51","author":"Hinrichs","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D32412042445","article-title":"Unusual eruption in association with sorafenib: A case of acquired perforating dermatosis, reactive perforating collagenosis type","volume":"24","author":"Lederhandler","year":"2018","journal-title":"Dermatol. Online J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0560.1996.tb01429.x","article-title":"The pathogenesis of the transepithelial elimination of the collagen bundles in acquired reactive perforating collagenosis. A light and electron microscopical study","volume":"23","author":"Yanagihara","year":"1996","journal-title":"J. Cutan. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000190246","article-title":"Silicon-related syndrome in dialysis patients","volume":"77","author":"Saldanha","year":"1997","journal-title":"Nephron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.2001.03982.x","article-title":"Immunohistochemical analysis of transforming growth factor-beta3 expression in acquired reactive perforating collagenosis","volume":"144","author":"Kawakami","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liarte, S., Bernab\u00e9-Garc\u00eda, \u00c1., and Nicol\u00e1s, F.J. (2020). Role of TGF-\u03b2 in Skin Chronic Wounds: A Keratinocyte Perspective. Cells, 9.","DOI":"10.3390\/cells9020306"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/153100350601800123","article-title":"Transforming growth factor-beta and wound healing","volume":"18","author":"Faler","year":"2006","journal-title":"Perspect. Vasc. Surg. Endovasc. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liu, B., Wu, Y., Wu, X., Zhong, X., Xue, R., and Zhang, Z. (2023). Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1240262"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4103\/ijdvl.IJDVL_113_16","article-title":"Expression of the receptor for advanced glycation end products in acquired reactive perforating collagenosis","volume":"83","author":"Akoglu","year":"2017","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13416","DOI":"10.1111\/srt.13416","article-title":"Acquired perforating dermatosis: A clinicopathologic study, and the features of dermoscopy and reflective confocal microscopy of 37 cases","volume":"29","author":"Gao","year":"2023","journal-title":"Skin. Res. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/jdv.14220","article-title":"Acquired perforating dermatosis: Clinicopathological study of 31 cases, emphasizing pathogenesis and treatment","volume":"31","author":"Coscojuela","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.abd.2020.06.022","article-title":"Trauma-induced acquired reactive perforating collagenosis","volume":"96","author":"Gontijo","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40001-021-00542-6","article-title":"Successful treatment of acquired reactive perforating collagenosis with itraconazole","volume":"26","author":"Ye","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ion, A., Popa, L.G., Porumb-Andrese, E., Doroban\u021bu, A.M., T\u0103tar, R., Giurc\u0103neanu, C., and Orzan, O.A. (2024). A Current Diagnostic and Therapeutic Challenge: Tinea Capitis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020376"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4103\/ijpm.ijpm_333_21","article-title":"Acquired reactive perforating collagenosis, a rare entity at uncommon site","volume":"65","author":"Ambalathinkal","year":"2022","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e4305","DOI":"10.1097\/MD.0000000000004305","article-title":"Acquired reactive perforating collagenosis: A report of a typical case","volume":"95","author":"Fei","year":"2016","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.abd.2020.03.015","article-title":"Case for diagnosis. Hyperpigmented and excoriated papules and nodules in a diabetic patient","volume":"95","author":"Sandoval","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3949\/ccjm.91a.23074","article-title":"Acquired reactive perforating collagenosis in a patient with diabetes","volume":"91","author":"Zhang","year":"2024","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"E20391","DOI":"10.1097\/MD.0000000000020391","article-title":"Acquired reactive perforating collagenosis: A case report and review of the literature","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"ref_39","first-page":"8","article-title":"Acquired reactive perforating collagenosis in skin of color","volume":"30","author":"McClure","year":"2024","journal-title":"Dermatol. Online J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1590\/S0365-05962013000100012","article-title":"Allopurinol in the treatment of acquired reactive perforating collagenosis","volume":"88","author":"Tilz","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ajd.13874","article-title":"Reactive perforating collagenosis successfully treated with dupilumab","volume":"63","author":"Loughlin","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1002\/iid3.574","article-title":"Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD","volume":"10","author":"Ying","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zheng, J., Ding, Y., Chen, Y., Shi, Y., and Gao, Y. (2024). Effectiveness of baricitinib in acquired reactive perforating collagenosis: A case report. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1388274"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2340\/00015555-1562","article-title":"Acquired reactive perforating collagenosis: A rare association with dermatomyositis","volume":"93","author":"Kikuchi","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.abd.2019.09.029","article-title":"Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves\u2019 disease","volume":"95","author":"Huseynova","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.25259\/IJDVL_288_20","article-title":"Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma","volume":"87","author":"Jiang","year":"2021","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-1248","article-title":"Reactive perforating collagenosis during erlotinib therapy","volume":"92","author":"Suzuki","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_48","first-page":"960","article-title":"Reactive perforating collagenosis: A rare side effect associated with sorafenib","volume":"112","author":"Zubiaur","year":"2020","journal-title":"Rev. Esp. Enfermedades Dig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e39071","DOI":"10.1097\/MD.0000000000039071","article-title":"A case report on acquired reactive perforating collagenosis","volume":"103","author":"Su","year":"2024","journal-title":"Medicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"adv40950","DOI":"10.2340\/actadv.v104.40950","article-title":"Ultra-high Potency Topical Corticosteroids as a Potential Trigger for Reactive Perforating Collagenosis","volume":"104","author":"Madanchi","year":"2024","journal-title":"Acta Derm. Venereol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/jid.2009.269","article-title":"AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: Epidermal-dermal interaction in acquired perforating dermatosis","volume":"130","author":"Fujimoto","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2230.1996.tb00094.x","article-title":"Reactive perforating collagenosis--transepidermal elimination of type IV collagen","volume":"21","author":"Herzinger","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"AB166","DOI":"10.1016\/j.jaad.2019.06.619","article-title":"Acquired perforating dermatosis successfully treated with doxycycline","volume":"81","author":"Chai","year":"2019","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/391\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:00:17Z","timestamp":1767618017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010391"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010391","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}